Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ChampionX Corp C.CHX


Primary Symbol: CHX

ChampionX Corporation is engaged in offering chemistry solutions, artificial lift systems, and engineered equipment and technologies that help companies drill for and produce oil and gas. The Company’s Production Chemical Technologies segment offers products and services that cover a range of onshore, offshore, and oil sands chemical solutions in production and midstream operations. Its Production & Automation Technologies segment offers products, technologies, and services that facilitate the extraction of oil and gas through artificial lift and digital automation applications. It designs, manufactures, markets a full range of artificial lift equipment, end-to-end automation, and digital solutions, and other production equipment and emissions monitoring solutions. Its Drilling Technologies segment offers polycrystalline diamond cutter (PDC) inserts, bearings, valves, and mining tools. Its Reservoir Chemical Technologies segment offers chemistry-oriented solutions and technologies.


NDAQ:CHX - Post by User

Post by hockeytownon Aug 02, 2017 4:46pm
176 Views
Post# 26540185

News

News

 

ChroMedX to move headquarters to Oakville

 

2017-08-02 16:27 ET - News Release

 

Mr. Ash Kaushal reports

CHROMEDX ANNOUNCES LAB EXPANSION FOR ACCELERATED TESTING AND DEVELOPMENT

ChroMedX Corp. will expand its lab capabilities and will relocate corporate and developmental headquarters to Oakville, Ont.

Since November 2014 ChroMedX's Canadian based development has taken place at the McMaster Innovation Park Lab under the leadership of Dr. Cynthia Balion and the Biointerface Institute under the leadership of Dr. Leyla Soleymani located at McMaster University of Hamilton, Ontario, Canada. ChroMedX has commenced construction on the new lab space and anticipates a formal relocation for September 1, 2017.

"Expanding our lab capabilities is an important step in the evolution of ChroMedX and growth of our team and knowledge base. This expansion will accelerate our development process and moving core development internal to the Company is a key step in preparation as we move towards commercialization of the HemoPalm technology. Our collaboration with McMaster Innovation Park and Biointerface Institute has been crucial to the successful development of the HemoPalm and we will continue to look to Cynthia, Leyla and their teams for guidance." said Ash Kaushal, President & CEO, ChroMedX Corp.

ChroMedX's partnership with the McMaster Innovation Park and Biointerface Institute has been integral to the development of the Company's HemoPalm Blood Analyzer System and the groups will continue to play a supporting role in the advancement of the technology.

In conjunction with ChroMedX's lab expansion the Company will now be looking to add several key personnel in a number of different fields to expand its internal development team. Interested parties can find more details and apply online on the Company's website under the careers tab.

ChroMedX Website

The Company recently announced the launch of a new website at www.ChroMedX.com. Investors and individuals interested in keeping up with latest news and updates can subscribe on the Home and News pages on the Company's website or reach out on the contact page.

About ChroMedX Corp.

ChroMedX Corp. is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing. The devices are protected by the Company's issued and pending patents, dealing with blood collection, analysis and plasma/serum processing.

The HemoPalm Handheld Blood Analyzer System is the only handheld blood analysis technology which combines Blood Gases & Electrolytes with full CO-oximetry. Currently this combination is not available on any of the handheld analyzers on the market. Existing technologies require users to purchase a second device to carry out the CO-oximetry. The Company's technology has the advantage of being able to offer a single handheld blood analyzer that provides all the required tests for Blood Gases & Electrolytes, with full CO-oximetry and bilirubin. Another competitive advantage of the HemoPalm system will be its ability to draw capillary blood directly from a pin-prickk site into the cartridge, providing an alternative to arterial blood. Drawing artegrial blood is painful and can cause nerve damage. CO-oximetry is the measurement of five different hemoglobin species in blood.

We seek Safe Harbor.

© 2017 Canjex Publishing Ltd. All rights reserved.

<< Previous
Bullboard Posts
Next >>